AbstractElucidating the molecular basis of hepatocellular carcinoma (HCC) is crucial to developing targeted diagnostics and therapies for this deadly disease. The landscape of somatic genomic rearrangements (GRs), which can lead to oncogenic gene fusions, remains poorly characterized in HCC. We have predicted 4314 GRs including large-scale insertions, deletions, inversions and translocations based on the whole-genome sequencing data for 88 primary HCC tumor/non-tumor tissues. We identified chromothripsis in 5 HCC genomes (5.7%) recurrently affecting chromosomal arms 1q and 8q. Albumin (ALB) was found to harbor GRs, deactivating mutations and deletions in 10% of cohort. Integrative analysis identified a pattern of paired intra-chromosomal tr...
Hepatocellular carcinoma (HCC) is a prevalent human cancer with rising incidence worldwide. Human HC...
Commercially available targeted panels miss genomic regions frequently altered in hepatocellular car...
Most cases of hepatocellular carcinoma (HCC) are already advanced at the time of diagnosis, which li...
Genetic alterations in specific driver genes lead to disruption of cellular pathways and are critica...
Background: Hepatocellular carcinoma (HCC) is a heterogeneous disease with high mortality rate. Rece...
International audienceHepatocellular carcinoma (HCC) is the most common primary liver malignancy. He...
Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide and has no effective trea...
Tissues from 98 human hepatocellular carcinomas (HCCs) obtained from hepatic resections were subject...
<div><p>Recent advances in sequencing technology have allowed us to profile genome-wide mutations of...
Background & Aims: Hepatocellular carcinoma (HCC) is highly malignant and prone to recur after surgi...
Liver cancer has the second highest worldwide cancer mortality rate and has limited therapeutic opti...
International audienceComparative genomic hybridization (CGH) was used to evaluate and map genomic a...
Most cancers are characterized by the somatic acquisition of genomic rearrangements during tumour ev...
International audienceIntegrative genomics helped characterize molecular heterogeneity in hepatocell...
BACKGROUND & AIMS: Many patients with hepatocellular carcinoma (HCC) have multiple lesions (prim...
Hepatocellular carcinoma (HCC) is a prevalent human cancer with rising incidence worldwide. Human HC...
Commercially available targeted panels miss genomic regions frequently altered in hepatocellular car...
Most cases of hepatocellular carcinoma (HCC) are already advanced at the time of diagnosis, which li...
Genetic alterations in specific driver genes lead to disruption of cellular pathways and are critica...
Background: Hepatocellular carcinoma (HCC) is a heterogeneous disease with high mortality rate. Rece...
International audienceHepatocellular carcinoma (HCC) is the most common primary liver malignancy. He...
Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide and has no effective trea...
Tissues from 98 human hepatocellular carcinomas (HCCs) obtained from hepatic resections were subject...
<div><p>Recent advances in sequencing technology have allowed us to profile genome-wide mutations of...
Background & Aims: Hepatocellular carcinoma (HCC) is highly malignant and prone to recur after surgi...
Liver cancer has the second highest worldwide cancer mortality rate and has limited therapeutic opti...
International audienceComparative genomic hybridization (CGH) was used to evaluate and map genomic a...
Most cancers are characterized by the somatic acquisition of genomic rearrangements during tumour ev...
International audienceIntegrative genomics helped characterize molecular heterogeneity in hepatocell...
BACKGROUND & AIMS: Many patients with hepatocellular carcinoma (HCC) have multiple lesions (prim...
Hepatocellular carcinoma (HCC) is a prevalent human cancer with rising incidence worldwide. Human HC...
Commercially available targeted panels miss genomic regions frequently altered in hepatocellular car...
Most cases of hepatocellular carcinoma (HCC) are already advanced at the time of diagnosis, which li...